Fluoxetine affects weight gain and expression of feeding peptides in the female goldfish brain

Regulatory Peptides

Volumn 155, Issue 1-3, 2009, Pages 99-104

  Mennigen, Jan A ^a   Harris, Ed A ^a   Chang, John P ^b   Moon, Thomas W ^a   Trudeau, Vance L ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Brain; Feeding; Fluoxetine; Gene expression; Goldfish; Growth hormone; Neuropeptides; Serotonin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; FLUOXETINE; GROWTH HORMONE; MESSENGER RNA; NEUROPEPTIDE; NUCLEAR FACTOR Y; SOMATOSTATIN; TACHYKININ; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 4;

ACCLIMATIZATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY GROWTH; BRAIN; CONTROLLED STUDY; FEMALE; FOOD INTAKE; GENE EXPRESSION; GOLDFISH; GROWTH HORMONE BLOOD LEVEL; HYPOTHALAMUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELENCEPHALON; UPREGULATION; WEIGHT GAIN;

ANIMALS; BRAIN; CORTICOTROPIN-RELEASING HORMONE; EATING; FEMALE; FLUOXETINE; GOLDFISH; GROWTH HORMONE; HYPOTHALAMUS; NERVE TISSUE PROTEINS; NEUROPEPTIDES; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN UPTAKE INHIBITORS; SOMATOSTATIN; TACHYKININS; TELENCEPHALON; WEIGHT GAIN;

CARASSIUS AURATUS; VERTEBRATA;

EID: 67349247480     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.01.001     Document Type: Article

References (49)

1. Weiger W.A. Serotonergic modulation of behavior. A phylogenetic overview. Biol Rev 72 (1997) 61-95
2. Volkoff H., and Peter R.E. Feeding behavior of fish and its control. Zebrafish 3 2 (2006) 131-140
3. Peter R.E., and Marchant T.A. The endocrinology of growth in carp and related species. Aquaculture 129 (1995) 299-321
4. J.I. Johnsson, B.T. Björnsson, Growth hormone increases growth rate, appetite and dominance in juvenile rainbow trout, Oncorhynchus mykiss. Anim Behav 48: 177-186.
5. De Pedro N., Pinillos M.L., Valenciano A.I., Alonso-Bedate M., and Delgado M.J. Inhibitory affect of serotonin on feeding behavior in goldfish: involvement of CRF. Peptides 19 3 (1998) 505-511
6. Marchant T.A., and Peter R.E. Seasonal variations in body growth rates and circulating levels of growth hormone in the goldfish, Carassius auratus. J Exp Zool 237 2 (1986) 231-239
7. Ortega V.A., Renner K.J., and Bernier N.J. Appetite-suppressing effects of ammonia exposure in rainbow trout associated with regional and temporal activation of brain monoaminergic and CRF systems. J Exp Biol 208 (2005) 1855-1866
8. Somoza G.M., and Peter R.E. Effects of serotonin on gonadotropin and growth hormone release from in vitro perifused goldfish pituitary fragments. Gen Comp Endocrinol 82 1 (1991) 103-110
9. Halford J.C.G., Harrold J.A., Boyland E.J., Laton C.L., and Blundell J.E. Effect on appetite expression and use for the treatment of obesity. Drugs 67 1 (2007) 27-55
10. Qiu J., Xue C., Bosch M.A., Murphy J.G., Fan W., Ronnekleiv O.K., and Kelly M.J. Serotonin 5-hydroxytryptamine receptor signaling in hypothalamic propiomelanocortin neurons: role in energy homeostasis in females. Mol Pharmacol 72 (2007) 885-896
11. Nonogaki K., Nozue K., Takahashi Y., Yamashita N., Hiraoka S., Kumano H., Kuboki T., and Oka Y. Fluvoxamine, a selective serotonin reuptake inhibitor, and 5HT2C receptor inactivation induce appetite-suppressing effects in mice via 5HT1B receptors. Int J Neuropsychopharmacol 10 (2007) 675-681
12. Ranganathan R., Sawin E.R., Trent C., and Horvitz H.R. Mutations in the C. elegans serotonin reuptake transporter MOD-5 reveal serotonin-dependent and -independent activities of fluoxetine. J Neurosci 21 16 (2001) 5871-5884
13. Metcalfe C.D., Miao X., Koenig B., and Struger J. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower great lakes, Canada. Environ Toxicol Chem 22 12 (2003) 2881-2889
14. Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A., Banks K.E., Johnson R.D., and Lewis R.J. Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 24 2 (2005) 464-469
15. Gould G.G., Brooks B.W., and Frazer A. 3H Citalopram biniding to SERT binding sites in the minnow brain. Basic Clin Pharmacol Toxicol 101 3 (2007) 203-210
16. Mennigen JA, Martyniuk CJ, Crump K, Xiong H, Zhao E, Popesku JT, Anisman H, Cossins AR, Xia X, Trudeau VL. The effect of fluoxetine on the reproductive axis of female goldfish, Carassius auratus. Physiol. Genomics ;35(3):273-82.
17. Narnaware Y.K., Peyon P.P., Lin X., and Peter R.E. Regulation of food intake by neuropeptide Y in goldfish. Am J Physiol Regul Integr Comp Physiol 279 (2000) 1025-1034
18. De Pedro N., Alonso-Gómez A.L., Gancedo B., Delgado M.J., and Alonso-Bedate M. Role of corticotropin-releasing factor (CRF) as a food intake regulator in goldfish. Physiol Behav 53 3 (1993) 517-520
19. Volkoff H., and Peter R.E. Effects of CART peptides on food consumption, feeding and associated behaviours in the goldfish, Carassius auratus: actions on neuropeptide Y- and orexin A-induced feeding. Brain Res 887 (2000) 125-133
20. Volkoff H., and Peter R.E. Characterization of two forms of cocaine- and amphetamine regulated transcript (CART) peptide precursors in goldfish: molecular cloning and distribution, modulation of expression by nutritional status, and interactions with leptin. Endocrinology 142 12 (2001) 5076-5088
21. Peyon P., Saied H., Lin X., and Peter R.E. Preprotachykinin gene expression in goldfish brain: sexual, seasonal, and postprandial variations. Peptides 21 (2000) 225-231
22. Hall T.R., Harvey S., and Scannes C.G. Control of growth-hormone secretion in the vertebrates - a comparative survey. Comp Biochem Physiol 84A (1986) 231-253
23. Yunker W.K., Smith S., Graves C., Davis P.J., Unniappan S., Rivier J.E., Peter R.E., and Chang J.P. Endogenous hypothalamic somatostatins differentially regulate growth hormone secretion form goldfish pituitary somatotropes in vitro. Endocrinology 144 (2003) 4031-4041
24. Canosa L.F., Unniapan S., and Peter R.E. Periprandial changes in growth hormone release in goldfish: role of somatostatin, ghrelin and and gastrin releasing peptide. Am J Physiol Regul Integr Comp Physiol 289 (2005) 125-133
25. Marchant T.A., Dulka J.G., and Peter R.E. Relationship between serum growth hormone levels and the brain and pituitary content of immunoreactive somatostatin in the goldfish, Carassius auratus. Gen Comp Endocrinol 73 (1989) 458-468
26. Nolan T., Hands R.E., and Bustin S.A. Quantification of mRNA using real-time RT-PCR. Nature Protoc 1 3 (2006) 1559-1582
27. Cantor J.M., Binik Y.M., and Pfaus J.G. Chronic fluoxetine inhibits sexual behavior in the male rat: reversal with oytocin. Psychopharmacology 144 (1999) 355-362
28. Choi S., Blake V., Cole S., and Fernstrom J.D. Effects of chronic fenfluramine on hypothalamic neuropeptide mRNA expression. Brain Res 1087 (2006) 83-86
29. Bandyopadhyay P., Swain S., and Mishra S. Growth and dietary utilization in goldfish (Carassius auratus Linn.) fed diets formulated with various local agro-produces. Bioresour Technol 96 (2005) 731-740
30. Kwon J., and Armbrust K. Laboratory persistence and fate of fluoxetine in aquatic environments. Environ Toxicol Chem 25 10 (2006) 2561-2568
31. Stanley B.G., Kyrkouli S., Lambert S., and Leibovitz S.F. Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7 (1986) 1189-1192
32. Dryden S., Frankish H.M., Wang Q., Pickavance L., and Williams G. The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats. Neuroscience 72 2 (1996) 557-566
33. Dryden S., Wang Q., Frankish H.M., and Williams G. Differential effects of 5HT1B/2C receptor agonist mCPP and the 5-HT1A agonist flesinoxan on hypothalamic neuropeptide Y in the rat: evidence that NPY may mediate serotonin's effects on food intake. Peptides 17 6 (1996) 943-949
34. Narnaware Y.K., and Peter R.E. Effects of food deprivation and refeeding on neuropeptide Y (NPY) mRNA levels in goldfish. Comp Biochem Physiol 129B (2000) 633-637
35. Torres G., Horrowitz J.M., Laflamme N., and Rivest S. Fluoxetine induces transcription of genes encoding c-fos, corticotrophin releasing factor and its type 1 receptor in rat brain. Neuroscience 87 2 (1998) 463-477
36. Gibbs D.M., and Vale W. Effect of the serotonin reuptake inhibitor fluoxetine on corticotrophin releasing factor and vasopressin secretion into hypophyseal portal blood. Brain Res 280 (1983) 176-179
37. Kageyama K., Tozawa F., Horiba N., Watanobe H., and Suda T. Serotonin stimulates corticotrophin releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats. Neurosci Lett 243 (1998) 17-20
38. Winberg S., Nilsson A., Hylland P., Söderstöm V., and Nilsson G.E. Serotonin as a regulator of hypothalamic-pituitary-interrenal activity in teleost fish. Neurosci Lett 230 2 (1997) 113-116
39. Doyon C., Gilmour K.M., Trudeau V.L., and Moon T.W. Cotricotropin-releasing factor and neuropeptide Y mRNA levels are elevated in the preoptic area of socially subordinate trout. Gen Comp Endocrinol 133 (2003) 260-271
40. Winberg S., and Le Page O. Elevation of brain 5-HT activity, POMC expression, and plasma cortisol in socially subordinate rainbow trout. Am J Physiol Regul Integr Comp Physiol 274 3 (1998) 645-654
41. Grigaschi G., Sironi F., and Samanin R. Stimulation of 5HT2A receptors in the paraventricular hypothalamus attenuates NPY-induced hyperphagia through activation of corticotrophin releasing factor. Brain Res 708 (1996) 173-176
42. Kristensen P., Judge M.E., Thim L., Ribel U., Christjansen K.N., Wulff B.S., Clausen J.T., Jensen P.B., Madsen O.D., Vrang N., Larsen P.J., and Hastrup S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393 (1998) 72-76
43. Nonogaki K., Nozue K., Takahashi Y., Yamashita N., Hiraoka S., Kumano H., Kuboki T., and Oka Y. Fluvoxamine, a selective serotonin reuptake inhibitor, and 5HT2C receptor inactivation induce appetite-suppressing effects in mice via 5HT1B receptors. Int J Neuropsychopharmacol 10 (2007) 675-681
44. Singru P.S., Mazumdar M., Barsagade V., Lechan R.M., Thim L., Clausen J.T., and Subhedar N. J Chem Neuroanat 36 3-4 (2008) 239-250
45. Liu T., Kim H., Arizmendi C., Kitano A., and Patel M.S. Identification of two missense mutations in a dihydrolipoamide dehydrogenase-deficient patient. Proc Natl Acad Sci USA 90 11 (1993) 5186-5190
46. Polakof S., and Soengas J.L. Involvement of lactate in glucose metabolism and glucosensing function in selected tissues in rainbow trout. J Exp Biol 211 (2008) 1075-1086
47. Stanley J.K., Ramirez A., Chambliss K., and Brooks B. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 69 (2007) 9-16
48. Brooks B.W., Foran C.M., Richards S.M., Weston J., Turner P.K., Stanley J.K., Solomon K.R., Slattery M., and La Point T.W. Aquatic ecotoxicology of fluoxetine. Toxicol Lett 142 3 (2003) 169-183 15
49. Khan I.A., and Thomas P. Lead and Aroclor 1254 disrupt reproductive neuroendocrine function in Atlantic croaker. Mar Environ Res 50 1-5 (2000) 119-123